Skip to main content
    H

    Hinge Health, Inc. (HNGE)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NYSE

    $121.29
    +5.90 (+5.11%)

    Market Cap: $9.38B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Hinge Health, Inc. (HNGE) P/E Ratio & Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Hinge Health (HNGE) trades at 56.9x trailing earnings and 12.2x sales. Its forward P/E is 37.5x. The median P/E across 7 similar companies is 35.0x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 51.7% higher over the next year. Its free cash flow yield is 3.2%.

    MultipleValue
    P/E (trailing)56.9x
    Forward P/E37.5x
    Price to sales12.2x
    Price to book32.8x
    EV/EBITDA39.6x
    Price to FCF31.1x
    EV/FCF30.4x
    PEGN/A
    FCF yield3.2%

    As of Nov 17, 2026

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About HNGE

    What is HNGE's forward P/E ratio?

    Hinge Health has a forward P/E ratio of 37.5x.

    Is HNGE stock overvalued?

    GNG's valuation label for HNGE is Overvalued. Its P/E of 56.9x compares with a median of 35.0x across 7 similar companies.

    What is HNGE's price to sales ratio?

    Hinge Health has a price to sales ratio of 12.2x.